Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 5879-5886

  Xue, Xiaochang ^a,b   Feng, Ting ^a   Yao, Suxia ^a   Wolf, Kyle J ^c   Liu, Chang Gong ^d   Liu, Xiuping ^d   Elson, Charles O ^c   Cong, Yingzi ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 23P40; LIGAND; MICRORNA; MICRORNA 10A; MYELOID DIFFERENTIATION FACTOR 88; RNA PRECURSOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COLITIS; COMMENSAL; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENTERITIS; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE HOMEOSTASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ANIMALS; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATION; INTERLEUKIN-12; INTERLEUKIN-23; INTESTINES; METAGENOME; MICE; MICE, INBRED C57BL; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 82755162151     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100535     Document Type: Article

References (50)

1. Mackie, R. I., A. Sghir, and H. R. Gaskins. 1999. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69: 1035S-1045S. (Pubitemid 29205082)
2. Ley, R. E., D. A. Peterson, and J. I. Gordon. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848. (Pubitemid 43261456)
3. Sartor, R. B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594. (Pubitemid 351173057)
4. Savage, D. C. 1977. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31: 107-133.
5. Artis, D. 2008. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8: 411-420. (Pubitemid 351733416)
6. Duerkop, B. A., S. Vaishnava, and L. V. Hooper. 2009. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31: 368-376.
7. Kaser, A., S. Zeissig, and R. S. Blumberg. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28: 573-621.
8. Hooper, L. V., T. S. Stappenbeck, C. V. Hong, and J. I. Gordon. 2003. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4: 269-273. (Pubitemid 36322137)
9. Ivanov, I. I., K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
10. Mazmanian, S. K., J. L. Round, and D. L. Kasper. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620-625. (Pubitemid 351769307)
11. Round, J. L., and S. K. Mazmanian. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107: 12204-12209.
12. Elson, C. O., Y. Cong, V. J. McCracken, R. A. Dimmitt, R. G. Lorenz, and C. T. Weaver. 2005. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206: 260-276. (Pubitemid 41105175)
13. Du, T., and P. D. Zamore. 2007. Beginning to understand microRNA function. Cell Res. 17: 661-663. (Pubitemid 47255935)
14. Winter, J., S. Jung, S. Keller, R. I. Gregory, and S. Diederichs. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11: 228-234.
15. Brennecke, J., A. Stark, R. B. Russell, and S. M. Cohen. 2005. Principles of microRNA-target recognition. PLoS Biol. 3: e85.
16. Gantier, M. P. 2010. New perspectives in MicroRNA regulation of innate immunity. J. Interferon Cytokine Res. 30: 283-289.
17. O'Connell, R. M., D. S. Rao, A. A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10: 111-122.
18. Taganov, K. D., M. P. Boldin, K. J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486. (Pubitemid 44267285)
19. Sheedy, F. J., E. Palsson-McDermott, E. J. Hennessy, C. Martin, J. J. O'Leary, Q. Ruan, D. S. Johnson, Y. Chen, and L. A. O'Neill. 2010. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11: 141-147.
20. Bazzoni, F., M. Rossato, M. Fabbri, D. Gaudiosi, M. Mirolo, L. Mori, N. Tamassia, A. Mantovani, M. A. Cassatella, and M. Locati. 2009. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA 106: 5282-5287.
21. Takagi, T., Y. Naito, K. Mizushima, I. Hirata, N. Yagi, N. Tomatsuri, T. Ando, Y. Oyamada, Y. Isozaki, H. Hongo, et al. 2010. Increased expression of micro- RNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J. Gastroenterol. Hepatol. 25(Suppl. 1): S129-S133.
22. Zhang, B., Q. Wang, and X. Pan. 2007. MicroRNAs and their regulatory roles in animals and plants. J. Cell. Physiol. 210: 279-289. (Pubitemid 44956872)
23. Calin, G. A., and C. M. Croce. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6: 857-866. (Pubitemid 44629897)
24. Trexler, P. C. 1983. Gnotobiotics. In The Mouse in Biomedical Research. Vol. III. Normative Biology, Immunology, and Husbandry. H. L. Foster, J. D. Small, and J. G. Fox, eds. Academic Press, San Diego, CA, p. 1-16.
25. Duck, L. W., M. R. Walter, J. Novak, D. Kelly, M. Tomasi, Y. Cong, and C. O. Elson. 2007. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm. Bowel Dis. 13: 1191-1201. (Pubitemid 47597766)
26. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
27. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263. (Pubitemid 38902439)
28. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826. (Pubitemid 47598622)
29. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2: 253-258. (Pubitemid 128373651)
30. Coombes, J. L., and F. Powrie. 2008. Dendritic cells in intestinal immune regulation. Nat. Rev. Immunol. 8: 435-446. (Pubitemid 351733420)
31. Strober, W. 2009. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 31: 377-388.
32. Cebra, J. J. 1999. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69: 1046S-1051S. (Pubitemid 29205083)
33. Lee, Y. K., and S. K. Mazmanian. 2010. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330: 1768-1773.
34. Pollard, M., and N. Sharon. 1970. Responses of the Peyer's Patches in Germ- Free Mice to Antigenic Stimulation. Infect. Immun. 2: 96-100.
35. Lee, Y. K., J. S. Menezes, Y. Umesaki, and S. K. Mazmanian. 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108(Suppl. 1): 4615-4622.
36. Strober, W., I. Fuss, and P. Mannon. 2007. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117: 514-521. (Pubitemid 46348505)
37. Wu, H. J., I. I. Ivanov, J. Darce, K. Hattori, T. Shima, Y. Umesaki, D. R. Littman, C. Benoist, and D. Mathis. 2010. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32: 815-827.
38. Wu, S., K. J. Rhee, E. Albesiano, S. Rabizadeh, X. Wu, H. R. Yen, D. L. Huso, F. L. Brancati, E. Wick, F. McAllister, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15: 1016-1022.
39. O'Connell, R. M., K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104: 1604-1609. (Pubitemid 46214637)
40. Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150-2158.
41. Androulidaki, A., D. Iliopoulos, A. Arranz, C. Doxaki, S. Schworer, V. Zacharioudaki, A. N. Margioris, P. N. Tsichlis, and C. Tsatsanis. 2009. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31: 220-231.
42. Tili, E., J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin, and C. M. Croce. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179: 5082-5089.
43. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202: 96-105. (Pubitemid 39576907)
44. Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644. (Pubitemid 37490789)
45. Ahern, P. P., C. Schiering, S. Buonocore, M. J. McGeachy, D. J. Cua, K. J. Maloy, and F. Powrie. 2010. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33: 279-288.
46. Elson, C. O., Y. Cong, C. T. Weaver, T. R. Schoeb, T. K. McClanahan, R. B. Fick, and R. A. Kastelein. 2007. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132: 2359-2370. (Pubitemid 46890867)
47. Hue, S., P. Ahern, S. Buonocore, M. C. Kullberg, D. J. Cua, B. S. McKenzie, F. Powrie, and K. J. Maloy. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203: 2473-2483. (Pubitemid 44664617)
48. Kullberg, M. C., D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, and A. Sher. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203: 2485-2494. (Pubitemid 44664618)
49. Fuss, I. J., C. Becker, Z. Yang, C. Groden, R. L. Hornung, F. Heller, M. F. Neurath, W. Strober, and P. J. Mannon. 2006. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12: 9-15. (Pubitemid 43032445)
50. Mannon, P. J., I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, et al.; Anti-IL-12 Crohn's Disease Study Group. 2004. Anti-interleukin-12 antibody for active Crohn's disease. [Published erratum appears in 2005 N. Engl. J. Med. 352: 1276.] N. Engl. J. Med. 351: 2069-2079. (Pubitemid 39482500)